tiprankstipranks
Advertisement
Advertisement

PLX Stock Latest News

Ram Selvaraju Reiterates Buy on Protalix, Maintains $12 Price Target on Elfabrio Momentum and Pipeline Upside
RatingsRam Selvaraju Reiterates Buy on Protalix, Maintains $12 Price Target on Elfabrio Momentum and Pipeline Upside
15d ago
PLX
Protalix Highlights Elfabrio Dosing Approvals and Growth Plans
PremiumCompany Announcements
Protalix Highlights Elfabrio Dosing Approvals and Growth Plans
20d ago
8K
PLX
Protalix Q1 Call: Milestone-Fueled Profit, Bold Targets
PremiumCompany Announcements
Protalix Q1 Call: Milestone-Fueled Profit, Bold Targets
28d ago
PLX
PLX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
PLX Upcoming Earnings Report: What to Expect?
1M ago
PLX
Protalix Earnings Call: EU Win, Cash Boost, Trade-Offs
PremiumCompany Announcements
Protalix Earnings Call: EU Win, Cash Boost, Trade-Offs
2M ago
PLX
Protalix: EU Approval and Commercial Tailwinds for Elfabrio Underscore Undervalued Upside
PremiumRatingsProtalix: EU Approval and Commercial Tailwinds for Elfabrio Underscore Undervalued Upside
3M ago
PLX
PLX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
PLX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
PLX
Protalix Gains EU Approval for Extended Elfabrio Dosing
Premium
Company Announcements
Protalix Gains EU Approval for Extended Elfabrio Dosing
3M ago
8K
PLX
Protalix, Chiesi Global Rare Diseases: EC approves dosing regimen for Elfabrio
PremiumThe Fly
Protalix, Chiesi Global Rare Diseases: EC approves dosing regimen for Elfabrio
3M ago
PLX
Protalix Advances RELEASE Gout Trial, Sharpening Its Long Term Biotech Upside
PremiumCompany Announcements
Protalix Advances RELEASE Gout Trial, Sharpening Its Long Term Biotech Upside
4M ago
PLX
Protalix Highlights Positive EMA Opinion on Elfabrio Dosing
PremiumCompany Announcements
Protalix Highlights Positive EMA Opinion on Elfabrio Dosing
4M ago
8K
PLX
Protalix Wins EMA Panel Backing for New Elfabrio Dosing
PremiumCompany Announcements
Protalix Wins EMA Panel Backing for New Elfabrio Dosing
4M ago
8K
PLX
Protalix, Chiesi Global: CHMP issues positive opinion for Elfabrio dosing
PremiumThe FlyProtalix, Chiesi Global: CHMP issues positive opinion for Elfabrio dosing
4M ago
PLX
Protalix outlines 2026 rare-disease growth and pipeline strategy
Premium
Company Announcements
Protalix outlines 2026 rare-disease growth and pipeline strategy
5M ago
8K
PLX
Protalix: Pipeline Expansion and Elfabrio Growth Drive Attractive Risk‑Reward and Undervalued Buy Rating
Premium
Ratings
Protalix: Pipeline Expansion and Elfabrio Growth Drive Attractive Risk‑Reward and Undervalued Buy Rating
6M ago
PLX
Protalix, Secarna Pharmaceuticals enter collaboration and option agreement
PremiumThe Fly
Protalix, Secarna Pharmaceuticals enter collaboration and option agreement
6M ago
PLX
Protalix price target lowered to $12 from $15 at H.C. Wainwright
PremiumThe Fly
Protalix price target lowered to $12 from $15 at H.C. Wainwright
7M ago
PLX
Protalix BioTherapeutics Reports Strong Revenue Growth in 2025
PremiumCompany Announcements
Protalix BioTherapeutics Reports Strong Revenue Growth in 2025
7M ago
PLX
Protalix BioTherapeutics’ Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
Protalix BioTherapeutics’ Earnings Call Highlights Growth and Challenges
7M ago
PLX
Protalix reports Q3 EPS 3c, consensus 5c
PremiumThe FlyProtalix reports Q3 EPS 3c, consensus 5c
7M ago
PLX
PLX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
PLX Upcoming Earnings Report: What to Expect?
7M ago
PLX
Protalix Seeks EMA Re-examination for Elfabrio Dosing
Premium
Company Announcements
Protalix Seeks EMA Re-examination for Elfabrio Dosing
7M ago
8K
PLX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >